A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
In a position paper published in The Leadership Quarterly earlier this year, Professor John Antonakis described factors that he believes are stifling the production of useful scientific research. In response to … Continue Reading ‘Bad science’ and how new ideas in scientific publishing can combat it
Over two days last month (17-18 January, 2017), around 250 delegates and exhibitors attended the 2017 European meeting of the International Society for Medical Publication Professionals (ISMPP) in London. The … Continue Reading Meeting report: Summary of Day 2 of the 2017 European #ISMPP Meeting
It has been suggested that a sizeable number of registered clinical trials fail to report their results, and that negative or null results are especially likely to remain unpublished. To help tackle … Continue Reading TrialsTracker attempts to identify trials with potentially unreported results
Making all clinical data, regardless of outcome, available to the public is one of the edicts of The World Health Organization and is a key factor in the drive for … Continue Reading Citation rate of clinical studies is skewed towards positive outcomes
In a recent article published in the Royal Society Open Science journal, Paul E. Smaldino and Richard McElreath describe the destructive and self-perpetuating cycle of “bad science”. The authors compare … Continue Reading The perpetuating cycle of “bad science”
Accurate reporting of data is an essential part of the research process. However, the misreporting of results in biomedical research publications, whether intentional or otherwise, can and does occur. This … Continue Reading Inappropriate image duplication found in 1 in 25 publications
Clinical trial data is often utilised for the purposes of clinical and health policy decision-making, with journal publications and registry reports the main sources for this information. Therefore, it is … Continue Reading Insufficient harms reporting: journal publications vs clinical study reports
As a prerequisite for publication of research, the International Committee of Medical Journal Editors (ICMJE) requires registration of clinical trials and recommends this to editors of medical journals. Similarly, provision … Continue Reading Retrospective vs. prospective registration of clinical trials – what is the norm?
Clinical trials with negative results have traditionally been viewed as ‘failures’. However, in the current age of transparency, there is a strong movement to ensure that all data, positive or negative … Continue Reading Phase III cancer clinical trials: the positive side of negative results
It is established best-practice that all clinical trial outcomes should be pre-specified in a trial protocol and on a clinical trial registry and then reported once the trial is complete. … Continue Reading Fixing the problem of outcome-switching in clinical trials
Data transparency is a hot topic at the moment and there are many different views, not only on the best way to proceed, but also on the advantages and disadvantages … Continue Reading Individual patient data sharing – have we considered all angles?
Author: Jo Chapman, PhD (Aspire Scientific Ltd) Over two days last week, around 250 delegates and exhibitors braved sub-zero temperatures to attend the European meeting of the International Society for … Continue Reading Meeting report: Summary of Day 2 of the 2016 European ISMPP Meeting
The 2016 European meeting of the International Society for Medical Publication Professionals (ISMPP) has just finished. Hopefully, the tweet stream below will be helpful in providing highlights of what was presented at … Continue Reading Want to know what the highlights were from the 2016 ISMPP European Meeting? See the #ISMPP tweet stream here
Videos from the recent Cochrane Colloquium are now available (see below). Presentations (within Plenaries I and II) include: The uneven future of evidence-based medicine (Ida Sim) Can too many systematic … Continue Reading [VIDEO] Plenaries from the recent Cochrane Colloquium
In 2005, the International Committee of Medical Journal Editors (ICMJE) introduced mandatory trial registration guidelines and member journals require prospective registration of trials prior to patient enrolment as a condition … Continue Reading Evidence that industry may be better than academia at prospective trial registration, though improvements are required
A study published in BMC Medicine this week assessed the consistency between the reporting of serious adverse events (SAEs) posted at ClinicalTrials.gov and those published in corresponding journal articles. Key findings … Continue Reading Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles
